iShares US Pharmaceuticals ETF
IHE
IHE
111 hedge funds and large institutions have $441M invested in iShares US Pharmaceuticals ETF in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 102 → 111 (+9)
4.11% more ownership
Funds ownership: 112.03% → 116.14% (+4.1%)
Holders
111
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$53.8M | |
| 2 | +$18.4M | |
| 3 | +$5.76M | |
| 4 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
+$4.52M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.93M |
Top Sellers
| 1 | -$6.62M | |
| 2 | -$4.54M | |
| 3 | -$4.35M | |
| 4 |
SFI
SPC Financial Inc
Rockville,
Maryland
|
-$1.74M |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$1.64M |